Total Payments
$10,934
2024 Payments
$75.04
Companies
15
Transactions
22
Medicare Patients
152
Medicare Billing
$24,263
Payment Breakdown by Category
Consulting$10,528 (96.3%)
Food & Beverage$242.46 (2.2%)
Other$150.00 (1.4%)
Education$13.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,528 | 4 | 96.3% |
| Food and Beverage | $242.46 | 12 | 2.2% |
| Honoraria | $150.00 | 1 | 1.4% |
| Education | $13.71 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $5,130 | 2 | $0 (2021) |
| Relypsa, Inc. | $3,950 | 1 | $0 (2020) |
| SANOFI PASTEUR INC. | $1,448 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $175.44 | 3 | $0 (2023) |
| Azurity Pharmaceuticals, Inc. | $43.09 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $31.47 | 1 | $0 (2022) |
| ANI Pharmaceuticals, Inc. | $26.62 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23.30 | 1 | $0 (2024) |
| RECORDATI_RARE_DISEASES_INC. | $20.91 | 1 | $0 (2022) |
| EUSA Pharma (US) LLC | $20.90 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.04 | 3 | ANI Pharmaceuticals, Inc. ($26.62) |
| 2023 | $14.84 | 1 | Alexion Pharmaceuticals, Inc. ($14.84) |
| 2022 | $1,536 | 5 | SANOFI PASTEUR INC. ($1,448) |
| 2021 | $5,148 | 3 | Alnylam Pharmaceuticals Inc. ($5,130) |
| 2020 | $4,159 | 8 | Relypsa, Inc. ($3,950) |
| 2018 | $2.25 | 2 | Retrophin, Inc. ($2.25) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/15/2024 | Azurity Pharmaceuticals, Inc. | KATERZIA (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.30 | General |
| 04/18/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Rare Disease | ||||||
| 11/21/2022 | SANOFI PASTEUR INC. | MENQUADFI (Biological) | Consulting Fee | Cash or cash equivalent | $1,448.00 | General |
| Category: Vaccines | ||||||
| 11/18/2022 | CMP Pharma, Inc. | Norliqva (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: calcium channel blocker liquid | ||||||
| 10/25/2022 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 10/25/2022 | EUSA Pharma (US) LLC | Sylvant (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Hematology | ||||||
| 05/10/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2021 | Baxter Healthcare | Renal - AK 98 (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Renal | ||||||
| 04/13/2021 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 03/25/2021 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| 12/10/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Immunology | ||||||
| 10/29/2020 | Azurity Pharmaceuticals, Inc. | Epaned (Drug), Qbrelis, Katerzia | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: pediatric hypertension | ||||||
| 09/15/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 03/06/2020 | Silvergate Pharmaceuticals, Inc. | Epaned (Drug), Qbrelis, Katerzia | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: pediatric hypertension | ||||||
| 03/06/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 03/06/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 03/06/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 02/12/2020 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $3,950.00 | General |
| Category: Hyperkalemia | ||||||
| 11/15/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 05/16/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.94 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 80 | $14,635 | $5,700 |
| 2022 | 3 | 51 | 146 | $26,785 | $10,678 |
| 2021 | 1 | 25 | 48 | $8,880 | $3,589 |
| 2020 | 2 | 42 | 68 | $14,784 | $4,297 |
Total Patients
152
Total Services
342
Medicare Billing
$24,263
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 33 | $5,940 | $2,946 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 47 | $8,695 | $2,754 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 84 | $15,540 | $5,739 | 36.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 45 | $8,100 | $3,564 | 44.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 13 | 17 | $3,145 | $1,375 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 48 | $8,880 | $3,589 | 40.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 24 | 38 | $9,234 | $2,553 | 27.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 30 | $5,550 | $1,743 | 31.4% |
About Daniel Feig, M.D., PH.D
Daniel Feig, M.D., PH.D is a Pediatric Nephrology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942380290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Feig, M.D., PH.D has received a total of $10,934 in payments from pharmaceutical and medical device companies, with $75.04 received in 2024. These payments were reported across 22 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($10,528).
As a Medicare-enrolled provider, Feig has provided services to 152 Medicare beneficiaries, totaling 342 services with total Medicare billing of $24,263. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Nephrology
- Location Birmingham, AL
- Active Since 10/17/2006
- Last Updated 01/19/2012
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1942380290
Products in Payments
- Veltassa (Drug) $3,950
- MENQUADFI (Biological) $1,448
- Ultomiris (Drug) $160.60
- Epaned (Drug) $36.84
- ACTHAR (Biological) $31.47
- PURIFIED CORTROPHIN GEL (Drug) $26.62
- KATERZIA (Drug) $25.12
- CYSTADROPS (Drug) $20.91
- Sylvant (Drug) $20.90
- Renal - AK 98 (Device) $17.52
- SOLIRIS (Biological) $14.84
- Norliqva (Drug) $14.34
- (815) Thiola (Drug) $13.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in Birmingham
David Askenazi, Md, MD
Pediatric Nephrology — Payments: $159,192
Pediatric Nephrology $159,192
Sahar Fathallah-Shaykh, Md, MD
Pediatric Nephrology — Payments: $4,553
Pediatric Nephrology $4,553
Dr. Kyle Deville, M.d, M.D
Pediatric Nephrology — Payments: $169.81
Pediatric Nephrology $169.81
Rebekah Sims, Crnp, CRNP
Pediatric Nephrology — Payments: $113.24
Pediatric Nephrology $113.24
Gabrielle Leonard, Md, MD
Pediatric Nephrology — Payments: $59.52
Pediatric Nephrology $59.52
William Tenney, M.d, M.D
Pediatric Nephrology
Pediatric Nephrology